Ignite Creation Date:
2024-05-05 @ 9:34 PM
Last Modification Date:
2024-10-26 @ 10:06 AM
Study NCT ID:
NCT00912847
Status:
COMPLETED
Last Update Posted:
2009-06-03
First Post:
2009-06-01
Brief Title:
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
Sponsor:
Chinese University of Hong Kong
Organization:
Chinese University of Hong Kong
Study Overview
Official Title:
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
Status:
COMPLETED
Status Verified Date:
2009-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is
1 To establish and compare the diagnostic utilities for hepatocellular carcinoma HCC screening tests of a HS-AFP b AFP USc AFP alone and d US alone within HBV carriers between age 40 and 70 years
2 To establish the cost-effectiveness of the screening tests
3 To compare tumor sizes resection rates and survival rates up to 18 months between those who were screened by HS-AFP those of a historical control group that was not screened
1 To establish and compare the diagnostic utilities for hepatocellular carcinoma HCC screening tests of a HS-AFP b AFP USc AFP alone and d US alone within HBV carriers between age 40 and 70 years
2 To establish the cost-effectiveness of the screening tests
3 To compare tumor sizes resection rates and survival rates up to 18 months between those who were screened by HS-AFP those of a historical control group that was not screened
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None